Profil
Matthew Durdy currently works at AQIX Ltd., as Chief Executive Officer, Cell Therapy Catapult Ltd., as Chief Executive Officer from 2020, and Parkinson's Disease Society of the United Kingdom, as Trustee.
Postes actifs de Matthew Durdy
| Sociétés | Poste | Début |
|---|---|---|
AQIX Ltd.
 AQIX Ltd. Pharmaceuticals: MajorHealth Technology Aqix Ltd is proud of the affiliations formed with many of its customers and trading partners in an endeavor to bring this unique fluid technology to the biomedical industry on a global scale. Recent events have highlighted the emergence of the company's fluid technology in applications involving stem cell therapy, organ transplant technology, human tissue storage and transportation and preclinical drug bioassay. | Directeur Général | - |
Cell Therapy Catapult Ltd.
 Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Directeur Général | 01/04/2020 |
Parkinson's Disease Society of the United Kingdom
 Parkinson's Disease Society of the United Kingdom Miscellaneous Commercial ServicesCommercial Services The Parkinson's Disease Society of the United Kingdom is a non-profit organization that aims to support research on Parkinson's disease. The non-profit company is based in London, UK. The British company provides health information about Parkinson's for patients, caregivers, and family members. The organization also supports researchers to involve patients and the public in their work. The company offers a Parkinson's Learning Pathway for occupational therapists, physiotherapists, and speech and language therapists. The company was founded in 1969 by Mali Jenkins. Caroline Rassell has been the CEO of the company since 2021. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
AQIX Ltd.
AQIX Ltd. Pharmaceuticals: MajorHealth Technology Aqix Ltd is proud of the affiliations formed with many of its customers and trading partners in an endeavor to bring this unique fluid technology to the biomedical industry on a global scale. Recent events have highlighted the emergence of the company's fluid technology in applications involving stem cell therapy, organ transplant technology, human tissue storage and transportation and preclinical drug bioassay. | Health Technology |
Cell Therapy Catapult Ltd.
Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
Parkinson's Disease Society of the United Kingdom
Parkinson's Disease Society of the United Kingdom Miscellaneous Commercial ServicesCommercial Services The Parkinson's Disease Society of the United Kingdom is a non-profit organization that aims to support research on Parkinson's disease. The non-profit company is based in London, UK. The British company provides health information about Parkinson's for patients, caregivers, and family members. The organization also supports researchers to involve patients and the public in their work. The company offers a Parkinson's Learning Pathway for occupational therapists, physiotherapists, and speech and language therapists. The company was founded in 1969 by Mali Jenkins. Caroline Rassell has been the CEO of the company since 2021. | Commercial Services |
